Canada Markets closed

OncoCyte Corporation (OCX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.4100-0.1100 (-3.12%)
At close: 4:00PM EDT
3.4100 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.91
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.5700
52 Week Low 31.4100
50-Day Moving Average 33.6200
200-Day Moving Average 34.5696

Share Statistics

Avg Vol (3 month) 3612.46k
Avg Vol (10 day) 3381.66k
Shares Outstanding 589.87M
Implied Shares Outstanding 6N/A
Float 853.01M
% Held by Insiders 110.33%
% Held by Institutions 163.54%
Shares Short (Sep. 29, 2021) 42.3M
Short Ratio (Sep. 29, 2021) 44.6
Short % of Float (Sep. 29, 2021) 43.76%
Short % of Shares Outstanding (Sep. 29, 2021) 42.48%
Shares Short (prior month Aug. 30, 2021) 42.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-826.26%

Management Effectiveness

Return on Assets (ttm)-18.06%
Return on Equity (ttm)-38.67%

Income Statement

Revenue (ttm)4.21M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)1,319.60%
Gross Profit (ttm)-639k
EBITDA -32.86M
Net Income Avi to Common (ttm)-27.5M
Diluted EPS (ttm)-0.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.53M
Total Cash Per Share (mrq)0.52
Total Debt (mrq)6.67M
Total Debt/Equity (mrq)6.50
Current Ratio (mrq)2.53
Book Value Per Share (mrq)1.20

Cash Flow Statement

Operating Cash Flow (ttm)-30.07M
Levered Free Cash Flow (ttm)-3.1M